【ChiCTR2300068085】A brief mindfulness intervention based on mobile apps to reduce anxiety and stress for Indonesian senior high school teachers: A Pilot Randomized Controlled Trial
ChiCTR2300068085
尚未开始
/
/
/
2023-02-06
/
/
Mental health
A brief mindfulness intervention based on mobile apps to reduce anxiety and stress for Indonesian senior high school teachers: A Pilot Randomized Controlled Trial
A brief mindfulness intervention based on mobile apps to reduce anxiety and stress for Indonesian senior high school teachers: A Pilot Randomized Controlled Trial
81116
The main objective of this pilot study is to evaluate the potential of the brief mindfulness based on mobile apps implementation in real-world settings. The secondary objectives are to determine the effectiveness of the brief-mindfulness intervention based on mobile apps (BM-MA) in reducing participant-reported anxiety symptoms; to evaluate the effectiveness of the BM-MA in reducing participant-reported stress symptoms and improving life satisfaction, self-compassion and sense of self-efficacy; and to evaluate the BM-MA potential for implementation in real-world settings.
随机平行对照
其它
Participants will be randomized by the built-in algorithm in the mobile app with 1:1 ratio to the treatment (BM-MA) and control group. The algorithm is designed for permuted block randomization where the total number of participants is set prior to the randomization.
无
Universitas Pendidikan Ganesha, Indonesia
/
289;290
/
2023-02-01
2023-12-31
/
1. Indonesian-certified senior high school teachers who are able to read and write in Indonesian; 2. Adults who are above 18 years of age; 3. Have access to smartphone use; 4. The total GAD-7 score is no more than 14 and the total GHQ-12 score is no more than 20.;
请登录查看The exclusion criteria for randomized controlled trial are set based on guidelines from MBSR (Santorelli, 2014) and MBCT (Crane et al., 2012), and include 1. Engagement with regular practice of mindfulness meditation [e.g for 15-20 mins a day, 2-3 times a week; 2. A history of, presence, or ongoing treatment for a psychological disorder; 3. A positive answer to GHQ-12 questions regarding suicidal; 4. Refusal to fill in the informed consent.;
请登录查看Universitas Pendidikan Ganesha, Indonesia
81116
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
Universitas Pendidikan Ganesha, Indonesia的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示:#脐带间充质干细胞(#hUC-MSCs)
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点,索弗度肽(survodutide)成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构:国家卫生健康委办公厅、 2026-11-10
-
颁布机构:国家卫健委(原国家卫计委) 2026-11-10
-
颁布机构:国家药品审评中心(CDE) 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-07
-
颁布机构:国家市场监督管理总局 2026-11-04

